Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04606173 · ClinicalTrials.gov registry record · NA

Adjunctive Team Enhanced Intervention to Improve Suicide Prevention Evidence-Based Practices in Primary Care

A NA study of Suicide Prevention, sponsored by Syracuse VA Medical Center.

Completed
Registry status
NA
Development phase
27
Enrollment target
1
Study location

NCT04606173 is a NA study of Suicide Prevention that has completed, run by Syracuse VA Medical Center. The registered enrollment target is 27 participants, below the 951-participant average among 21 other Suicide Prevention trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04606173, a NA study of Suicide Prevention, has completed, sponsored by Syracuse VA Medical Center.

COMPLETED
Registry status
NA
Development phase
27 participants
Enrollment target
1
Study location

Study Summary

The purpose of the proposed study is to evaluate the feasibility and acceptability of a brief educational intervention (TEACH) that includes evidence-based strategies designed to improve task-specific teamwork and its impact (vs. standard practice) on teamwork among primary care team members and on evidence-based suicide prevention care provided to Veterans in Primary Care.

Conditions Studied

Interventions

  • OTHER Team Education for Adopting Changes in Healthcare (TEACH)

Study Locations (1)

New York

  • Syracuse VA Medical Center - Syracuse

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2021-06-24
Est. Completion 2023-04-17
Phase NA

Sponsor

Syracuse VA Medical Center

8 total trials

What the Registry Record Tells You About NCT04606173

The ClinicalTrials.gov registry entry for NCT04606173 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 951-participant average among 21 other Suicide Prevention trials with a reported enrollment target (97% lower). The listed sponsor is Syracuse VA Medical Center, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Suicide Prevention appearing as the primary indexed condition, and to 1 intervention - of which Team Education for Adopting Changes in Healthcare (TEACH) is the first listed.

NCT04606173 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04606173 about?

NCT04606173 is a clinical study titled "Adjunctive Team Enhanced Intervention to Improve Suicide Prevention Evidence-Based Practices in Primary Care". The purpose of the proposed study is to evaluate the feasibility and acceptability of a brief educational intervention (TEACH) that includes evidence-based strategies designed to improve task-specific teamwork and its impact (vs. standard practice) on teamwork among primary care team members and on ...

What is the current status of trial NCT04606173?

This trial is currently completed. It is a NA study. The enrollment target is 27 participants. The study started on 2021-06-24. Estimated completion is 2023-04-17.

What conditions does trial NCT04606173 study?

This clinical trial studies the following conditions: Suicide Prevention.

What interventions are being tested in trial NCT04606173?

The interventions under investigation include: Team Education for Adopting Changes in Healthcare (TEACH) (OTHER).

Who is sponsoring clinical trial NCT04606173?

This trial is sponsored by Syracuse VA Medical Center, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04606173 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide Prevention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.